Hodges Capital Management Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1337263 DALLAS, TX

Position in LGND

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$7,410,413

New position

Shares Held

23,444

first reported quarter

Ownership

0.118%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#89

of 411 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 70% Shared 0% None 30%

Healthcare · as of Jun 30, 2026

Hodges Capital Management Inc. holds $17,747,610 across 2 Biotechnology names. LGND ranks #2 (41.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	HALO	Halozyme Therapeutics, Inc.	132,071	$10,337,197
2	LGND	Ligand Pharmaceuticals Inc This page	23,444	$7,410,413

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,410,413	23,444	—	Shares	Sole	2026-08-03
No filing history on record for this holder in this stock.